Records containing: Solid Tumor Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-103, a Nectin4/Trop2 ADC, as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-14Single-arm Open-label Phase I/II Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
-
CLINICAL_TRIALS study record update · 2026-04-07Phase I Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-02A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2026-03-25Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-18A Phase I/Ib, First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of DF6215 Monotherapy and in Combination Therapy in Patients With Advanced (Unresectable, Recurrent, or Metastatic) Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of QLS5212 Monotherapy in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-10Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-02-27A Multicenter, Open-Label, Phase Ib/II Clinical Trial of IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-20Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-20A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-18A Phase 1 Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLT012 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-04Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application
-
CLINICAL_TRIALS study record update · 2026-01-21Study Evaluating 68Ga-FAPI-46 Tumor Microenvironment Interaction in Solid Tumor Patients
-
CLINICAL_TRIALS study record update · 2025-12-26Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase I/Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of Pl3Kα-Selective Inhibitor RP903 (JS105) in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-12-18Implementation of the Methylome in the Characterization of Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-12-08A Phase I Study Evaluating the Preliminary Efficacy and Safety of WTX212A Injection as Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-12-04A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Refractory Cancers
-
CLINICAL_TRIALS study record update · 2025-12-03An Open-Label Phase 1/2A Study of GV20-0251 in Participants With Advanced and/or Refractory Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-12-02Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol
-
CLINICAL_TRIALS study record update · 2025-11-17A Phase Ib/ II Clinical Study to Evaluate the Safety ,Torlerbility , and Efficacy of HLX43 (Anti-PD-L1 ADC) in Combination With Serplulimab (Anti-PD-1 Humanized Monocl ) in Patients With Advanced/Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-16A Pilot Distress Screening and Referral Program to Detect Comorbid Psychosocial Distress in NYC Safety Net Hospitals Serving Diverse and Underserved Patients Diagnosed With Cancer
-
CLINICAL_TRIALS study record update · 2025-10-10Imaging of Solid Tumors Using DLL3 SPECT
-
CLINICAL_TRIALS study record update · 2025-08-28Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors